Shuangyue Pan

机构：Zhejiang Chinese Medical University, Hangzhou Medical College

发表论文 5 篇 · 总被引 42 次 · h-index 3

代表论文

Comparison of the efficacy and safety of fruquintinib and regorafenib in the treatment of metastatic colorectal cancer: A real-world study (2023 · Frontiers in Oncology · 被引 28)
A Comparison of Bevacizumab Plus TAS-102 and TAS-102 Monotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis (2021 · Frontiers in Oncology · 被引 11)
Management and Thinking on the Treatment of Cancer Patients During the COVID-19 (2021 · Frontiers in Molecular Biosciences · 被引 3)
Targeting 5-HT to Alleviate Dose-Limiting Neurotoxicity in Nab-Paclitaxel-Based Chemotherapy (2025 · Neuroscience Bulletin)
Tumor-mutation burden as a marker for immunotherapy of pancreatic cancer: the case report and literature review. (2022 · PubMed)